BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
96 hedge funds and large institutions have $263M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
79% less call options, than puts
Call options by funds: $350K | Put options by funds: $1.69M
Holders
96
Holding in Top 10
1
Calls
$350K
Puts
$1.69M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$11.3M | |
| 3 | +$3.34M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.83M |
| 5 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
+$2.6M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$7.11M | |
| 3 | -$5.3M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.48M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$998K |